These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25400117)

  • 1. Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo.
    Denicolaï E; Baeza-Kallee N; Tchoghandjian A; Carré M; Colin C; Jiglaire CJ; Mercurio S; Beclin C; Figarella-Branger D
    Oncotarget; 2014 Nov; 5(21):10934-48. PubMed ID: 25400117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma.
    Berges R; Denicolai E; Tchoghandjian A; Baeza-Kallee N; Honore S; Figarella-Branger D; Braguer D
    Cell Death Dis; 2018 Sep; 9(10):984. PubMed ID: 30250248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
    Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
    Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma.
    González-Gómez P; Crecente-Campo J; Zahonero C; de la Fuente M; Hernández-Laín A; Mira H; Sánchez-Gómez P; Garcia-Fuentes M
    Oncotarget; 2015 May; 6(13):10950-63. PubMed ID: 25860932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.
    Berges R; Baeza-Kallee N; Tabouret E; Chinot O; Petit M; Kruczynski A; Figarella-Branger D; Honore S; Braguer D
    Oncotarget; 2014 Dec; 5(24):12769-87. PubMed ID: 25473893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells.
    Höring E; Podlech O; Silkenstedt B; Rota IA; Adamopoulou E; Naumann U
    Anticancer Res; 2013 Apr; 33(4):1351-60. PubMed ID: 23564772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.
    Tchoghandjian A; Baeza-Kallee N; Beclin C; Metellus P; Colin C; Ducray F; Adélaïde J; Rougon G; Figarella-Branger D
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S608-19. PubMed ID: 21989663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy.
    Liang J; Piao Y; Henry V; Tiao N; de Groot JF
    Oncotarget; 2015 Oct; 6(31):31479-92. PubMed ID: 26362401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic effects of miR-10b in glioblastoma stem cells.
    Guessous F; Alvarado-Velez M; Marcinkiewicz L; Zhang Y; Kim J; Heister S; Kefas B; Godlewski J; Schiff D; Purow B; Abounader R
    J Neurooncol; 2013 Apr; 112(2):153-63. PubMed ID: 23307328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line.
    Dos Santos C; Karaky R; Renoir D; Hamma-Kourbali Y; Albanese P; Gobbo E; Griscelli F; Opolon P; Dalle S; Perricaudet M; Courty J; Delbé J
    Int J Cancer; 2010 Sep; 127(5):1038-51. PubMed ID: 20013808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
    Floyd DH; Kefas B; Seleverstov O; Mykhaylyk O; Dominguez C; Comeau L; Plank C; Purow B
    Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
    Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W
    Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation.
    Li RZ; Fan XX; Duan FG; Jiang ZB; Pan HD; Luo LX; Zhou YL; Li Y; Yao YJ; Yao XJ; Leung EL; Liu L
    Cell Death Dis; 2018 Jun; 9(6):696. PubMed ID: 29899551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
    Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
    Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.
    Du S; Sarver JG; Trabbic CJ; Erhardt PW; Schroering A; Maltese WA
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):237-254. PubMed ID: 30426158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
    Drucker KL; Paulsen AR; Giannini C; Decker PA; Blaber SI; Blaber M; Uhm JH; O'Neill BP; Jenkins RB; Scarisbrick IA
    Neuro Oncol; 2013 Mar; 15(3):305-18. PubMed ID: 23307575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of aldoxorubicin in an intracranial xenograft mouse model of human glioblastoma.
    Marrero L; Wyczechowska D; Musto AE; Wilk A; Vashistha H; Zapata A; Walker C; Velasco-Gonzalez C; Parsons C; Wieland S; Levitt D; Reiss K; Prakash O
    Neoplasia; 2014 Oct; 16(10):874-82. PubMed ID: 25379024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner.
    Lindemann C; Marschall V; Weigert A; Klingebiel T; Fulda S
    Neoplasia; 2015 Jun; 17(6):481-9. PubMed ID: 26152356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.